IP Library › Granted Patent US 7,928,100
Granted Patent B2
US 7,928,100 · App. 12/245,619 · Granted Apr 19, 2011

Quinolone analogs and methods related thereto

Assignee: Cylene Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,928,100
App. No.
12/245,619
Granted
Apr 19, 2011
Kind
B2
Abstract

The present invention provides novel quinolone compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.

Claims (5)

1. A compound having the structure:

or a pharmaceutically acceptable salt or ester thereof.

2. A pharmaceutical composition comprising a compound having the structure:

or a pharmaceutically acceptable salt or ester thereof; and

a pharmaceutically acceptable excipient.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2013
From: CYLENE PHARMACEUTICALS, INC.
To: SENHWA BIOSCIENCES, INC.
Reel/Frame 030554/0301 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2008
From: NAGASAWA, JOHNNY YASUO; PIERRE, FABRICE; HADDACH, MUSTAPHA; SCHWAEBE, MICHAEL; DARJANIA, LEVAN; WHITTEN, JEFFREY P.
To: CYLENE PHARMACEUTICALS, INC.
Reel/Frame 021846/0193 →
Continuity (4)
Provisional Application 60978042 · Oct 5, 2007
Provisional Application 61038681 · Mar 21, 2008
Provisional Application 61045933 · Apr 17, 2008
Related Publication 20090093455A1 · Apr 9, 2009